losartan and arachidonyltrifluoromethane

losartan has been researched along with arachidonyltrifluoromethane in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bassenge, E; Schwemmer, M; Sommer, O	1

Other Studies

1 other study(ies) available for losartan and arachidonyltrifluoromethane

Article	Year
Angiotensin receptor blocker losartan suppresses platelet activity by interfering with thromboxane signaling. Cardiovascular drugs and therapy, 2001, Volume: 15, Issue:4 Topics: Angiotensin Receptor Antagonists; Animals; Arachidonic Acids; Benzimidazoles; Biphenyl Compounds; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Imidazoles; Losartan; Phospholipases A; Phospholipases A2; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Receptors, Thromboxane; Renin-Angiotensin System; Signal Transduction; Tetrazoles; Thromboxane A2	2001

Article

Year

Angiotensin receptor blocker losartan suppresses platelet activity by interfering with thromboxane signaling.

Cardiovascular drugs and therapy, 2001, Volume: 15, Issue:4

Topics: Angiotensin Receptor Antagonists; Animals; Arachidonic Acids; Benzimidazoles; Biphenyl Compounds; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Imidazoles; Losartan; Phospholipases A; Phospholipases A2; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Receptors, Thromboxane; Renin-Angiotensin System; Signal Transduction; Tetrazoles; Thromboxane A2

2001